Gene therapy for cholesterol: Initial test results cheer

A new gene editing medicine, VERVE-102, offers hope for millions with heart conditions. Eli Lilly's drug showed significant reductions in bad cholesterol. This one-time infusion could transform heart disease management. Larger trials are planned, with a Phase II trial starting soon. This approach may eventually benefit broader populations at high cardiovascular risk.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/C6LDpzy
via IFTTT

Read More

Skymap Pharma to buy state-run Indian Medicines Pharma for Rs 121 crore

The inter-ministerial committee has officially sanctioned the acquisition of the Indian Medicines Pharmaceutical Corporation by Skymap Pharmaceuticals for a whopping ₹121 crore, securing a 100% ownership stake. This pivotal transaction marks the first strategic sell-off of a public sector entity in FY25, with the award letter now in circulation.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/ZGuVTd5
via IFTTT

Read More

Government okays Skymap Pharmaceuticals' Rs 121-cr bid to buy IMPCL

The government has approved the sale of Indian Medicines Pharmaceutical Corporation Ltd. Skymap Pharmaceuticals Pvt Ltd will acquire the company for over Rs 121 crore. This strategic sale involves 100 percent stake and management control. IMPCL manufactures Ayurvedic and Unani medicines. The approval followed a competitive bidding process. The transaction is now being finalized.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/DhAR0gZ
via IFTTT

Read More

Health services, medical education expansion to be driven by modern tech: Yogi Adityanath

Uttar Pradesh Chief Minister Yogi Adityanath reviewed health and medical education. He stressed improving treatment quality and expanding services. Medical colleges and nursing institutions will be strengthened with modern technology. Ayushman Yojana support for the poor was highlighted. Efforts are underway to enhance emergency services and control communicable diseases.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/zD0yKUT
via IFTTT

Read More

India medical tourism market feels the weight of Iran war

India's medical tourism sector faces challenges as West Asian tensions continue. Overseas patient numbers remain lower than before the conflict intensified. Hospital chains report a gradual increase in inquiries and arrivals, but traffic has not fully recovered. Prolonged geopolitical uncertainty could also raise operating costs through inflation and currency fluctuations.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/fNZH7yg
via IFTTT

Read More

Park Medi World to acquire Medicity Hospital in Rudrapur, enter Uttarakhand

Hospital chain Park Medi World Limited is acquiring The Medicity Hospital in Rudrapur. The deal is valued at Rs 177 crore and is an all-cash transaction. This acquisition marks Park Group's entry into Uttarakhand. The Medicity Hospital is a multi-super speciality facility with 330 beds. This move aligns with the company's growth strategy to expand its network in underserved markets.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/HeNUzh6
via IFTTT

Read More

Sakar Healthcare partners with Zydus Lifesciences for GCC Markets

Sakar Healthcare has partnered with Zydus Lifesciences to supply oncology products in GCC countries and other emerging markets. This marks the company's 40th global agreement in the anti-cancer segment. Sakar Healthcare is expanding its international oncology business and strengthening its presence in emerging markets. The company is also progressing with regulatory filings and approvals in highly regulated markets.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/QytHJAx
via IFTTT

Read More